AMP‐activated protein kinase: a core signalling pathway in the heart
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Over the past decade, AMP‐activated protein kinase (AMPK) has emerged as an important intracellular signalling pathway in the heart. Activated AMPK stimulates the production of ATP by regulating key steps in both glucose and fatty acid metabolism. It has an inhibitory effect on cardiac protein synthesis. AMPK also interacts with additional intracellular signalling pathways in a coordinated network that modulates essential cellular processes in the heart. Evidence is accumulating that AMPK may protect the heart from ischaemic injury and limit the development of cardiac myocyte hypertrophy to various stimuli. Heart AMPK is activated by hormones, cytokines and oral hypoglycaemic drugs that are used in the treatment of type 2 diabetes. The tumour suppressor LKB1 is the major regulator of AMPK activity, but additional upstream kinases and protein phosphatases also contribute. Mutations in the regulatory γ2 subunit of AMPK lead to an inherited syndrome of hypertrophic cardiomyopathy and ventricular pre‐excitation, which appears to be due to intracellular glycogen accumulation. Future research promises to elucidate the molecular mechanisms responsible for AMPK activation, novel downstream AMPK targets, and the therapeutic potential of targeting AMPK for the prevention and treatment of myocardial ischaemia or cardiac hypertrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., & Hardie, D. G. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.009 · Cited by 1,589 · cited 1×
“Calcium/calmodulin-dependent kinase kinase b (CaMKKb) has been identified as an upstream AMPK kinase in non-cardiac cells (Hawley et al. 2005, Hong et al. 2005).”
BackgroundMatsui, Y., Takagi, H., Qu, X., Abdellatif, M., Sakoda, H., Asano, T., Levine, B., & Sadoshima, J. (2007) · Circulation Research · doi:10.1161/01.res.0000261924.76669.36 · Cited by 1,505
Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E
Fingar, D. C., Salama, S., Tsou, C., Harlow, E., & Blenis, J. (2002) · Genes & Development · doi:10.1101/gad.995802 · Cited by 1,093 · cited 1×
“In addition, activated AMPK inhibits the mammalian target of rapamycin (mTOR) pathway, which reduces p70/S6 kinase activation (Wang et al. 2001, Fingar et al. 2002).”
BackgroundShibata, R., Sato, K., Pimentel, D. R., Takemura, Y., Kihara, S., Ohashi, K., Funahashi, T., Ouchi, N., & Walsh, K. (2005) · Nature Medicine · doi:10.1038/nm1295 · Cited by 982 · cited 10×
“AMPK activation reduces apoptosis in the perfused mouse heart during ischaemia-reperfusion (Shibata et al. 2005).”
BackgroundInfluentialTee, A. R., Fingar, D. C., Manning, B. D., Kwiatkowski, D. J., Cantley, L. C., & Blenis, J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202476899 · Cited by 827 · cited 2×
“AMPK phosphorylates TSC2 at Thr1227 and Ser1345, causing its activation and subsequent inhibition of mTOR (Tee et al. 2002).”
BackgroundRussell, R. R., Li, J., Coven, D. L., Pypaert, M., Zechner, C., Palmeri, M., Giordano, F. J., Mu, J., Birnbaum, M. J., & Young, L. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19297 · Cited by 738
Self-citationAdiponectin-mediated modulation of hypertrophic signals in the heart
Shibata, R., Ouchi, N., Ito, M., Kihara, S., Shiojima, I., Pimentel, D. R., Kumada, M., Sato, K., Schiekofer, S., Ohashi, K., et al. (2004) · Nature Medicine · doi:10.1038/nm1137 · Cited by 671 · cited 5×
“2005) and the inhibitory effects of adiponectin in cardiac hypertrophy (Shibata et al. 2004).”
BackgroundInfluentialMammalian AMP-activated protein kinase subfamily
Stapleton, D., Mitchelhill, K. I., Gao, G., Widmer, J., Michell, B. J., Teh, T., House, C. M., Fernandez, C. S., Cox, T., Witters, L. A., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.2.611 · Cited by 652 · cited 1×
“Witters’ and Kemp’s groups described the tissue-specific expression of AMPK a1 and a2 subunit isoforms, showing predominance of a2 subunit expression in the heart (Stapleton et al. 1996).”
BackgroundCharacterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding
CHEUNG, P. C. F., SALT, I. P., DAVIES, S. P., HARDIE, D. G., & CARLING, D. (2000) · Biochemical Journal · doi:10.1042/bj3460659 · Cited by 637
(1995) · FEBS Letters · doi:10.1016/0014-5793(95)01368-7 · Cited by 595 · cited 2×
“Both PP2A and PP2C have been shown to dephosphorylate AMPK in vitro (Davies et al. 1995, Kudo et al. 1996).”
Background
Cited by
PI3K/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis
Schultze, S. M., Hemmings, B. A., Niessen, M., & Tschopp, O. (2012) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002109 · Cited by 540
Watkins, H., Ashrafian, H., & Redwood, C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra0902923 · Cited by 496
AMPK: energy sensor and survival mechanism in the ischemic heart
Qi, D., & Young, L. H. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.05.010 · Cited by 287
Self-citationMitochondrial adaptations to physiological vs. pathological cardiac hypertrophy
Abel, E. D., & Doenst, T. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr015 · Cited by 263
“–104 AMPK is activated in the heart in pathological hypertrophy and in response to exercise.(105,106) However, it is likely that their contribution to changes in mitochondrial function are distinct in patho-”
Zhao, Y., Zhang, L., Qiao, Y., Zhou, X., Wu, G., Wang, L., Peng, Y., Dong, X., Huang, H., Si, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075927 · Cited by 138
“Furthermore, emerging evidence demonstrated that AMPK may regulate autophagy in diabetic cardiomyopathy [43].”
Background
Metadata
- Authors
- Kim, A. S., Miller, E. J., & Young, L. H.
- Venue
- Acta Physiologica
- Publisher
- Wiley
- Published
- 2009-04
- Volume
- 196
- Issue
- 1
- Pages
- 37-53
- ISSN
- 1748-1708 (ISSN-L)
- 1748-1716
- OpenAlex
- W2015633910
- Cited by
- 98
- References
- 22
- FWCI
- 5.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: AMP‐activated protein kinase: a core signalling pathway in the heart. https://app.cochat.ai/papers/10.1111/j.1748-1716.2009.01978.x
- The paper
- Kim, A. S., Miller, E. J., & Young, L. H. (2009). AMP‐activated protein kinase: a core signalling pathway in the heart. Acta Physiologica. https://doi.org/10.1111/j.1748-1716.2009.01978.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.